Bumper Offer - Urjas oil Just @ Rs. 1
Rafle 200 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Hepatic Encephalopathy. Other than this, Rafle 200 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Rafle 200 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Rafle 200 Tablet include Flatulence, Bloating or fullness, Constipation. Besides the aforementioned side effects, there are other adverse effects of Rafle 200 Tablet as well, which are listed below. Such side effects of Rafle 200 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Rafle 200 Tablet's effect during pregnancy is Severe and Severe while nursing. Warnings related to Rafle 200 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
The section on Rafle 200 Tablet contraindications lists all such conditions.
Drug reaction of Rafle 200 Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Rafle 200 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Rafle 200 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Rafle 200 Tablet is used -
Moderate
Mild
Common
Is the use of Rafle 200 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Rafle. If you are pregnant, do not take Rafle without a doctor's advice.
Is the use of Rafle 200 Tablet safe during breastfeeding?
Taking Rafle may lead to serious side effects if you are breastfeeding. Rafle should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Rafle 200 Tablet on the Kidneys?
Rafle is completely safe for kidneys.
What is the effect of Rafle 200 Tablet on the Liver?
Side effects of Rafle rarely affect the liver.
What is the effect of Rafle 200 Tablet on the Heart?
You can take Rafle without any fear of damage to the heart.
Rafle 200 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rafle 200 Tablet unless your doctor advises you to do so -
Is this Rafle 200 Tablet habit forming or addictive?
No, there is no any evidence that Rafle 200 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Rafle 200 Tablet as it does not make you drowsy.
Is it safe?
Yes, but take Rafle 200 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, the use of Rafle 200 Tablet in mental disorders is not effective.
Interaction between Food and Rafle 200 Tablet
Taking Rafle 200 Tablet with food is safe.
Interaction between Alcohol and Rafle 200 Tablet
Due to lack of research, there is no information about the side effects of taking Rafle 200 Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
